Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Cascadion™ SM Immunosuppressants Panel, Stability of Tacrolimus, Cyclosporine A, Everolimus and Sirolimus in Whole Blood Patient Samples

NCT05274308 is registered in ClinicalTrials.gov with Thermo Fisher Scientific Oy as lead sponsor.

NCT NCT05274308
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05274308 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Cascadion™ SM Immunosuppressants Panel, Stability of Tacrolimus, Cyclosporine A, Everolimus and Sirolimus in Whole Blood Patient Samples
Lead sponsor
Thermo Fisher Scientific Oy
Phase
Observational
Overall status
Completed
Start date
February 7, 2022
Completion date
July 26, 2022
Enrollment
46 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

transplantation drugs stability